Ultragenyx Pharmaceutical Inc. (RARE) Net income 2016–2025
Ultragenyx Pharmaceutical Inc. (RARE) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$575.0MFY2025 · since FY2016: -$245.9M → -$575.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$575.0M | -1.1% |
| FY2024 | -$569.0M | +6.3% |
| FY2023 | -$607.0M | +14.2% |
| FY2022 | -$707.4M | -55.8% |
| FY2021 | -$454.0M | -143.4% |
| FY2020 | -$186.6M | +53.7% |
| FY2019 | -$402.7M | -103.8% |
| FY2018 | -$197.6M | +34.6% |
| FY2017 | -$302.1M | -22.9% |
| FY2016 | -$245.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice